X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5677) 5677
Newspaper Article (752) 752
Book Chapter (53) 53
Publication (15) 15
Book / eBook (12) 12
Magazine Article (10) 10
Trade Publication Article (3) 3
Conference Proceeding (2) 2
Dissertation (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4332) 4332
neuroendocrine tumors (2581) 2581
oncology (2356) 2356
male (2069) 2069
female (1764) 1764
middle aged (1536) 1536
cancer (1477) 1477
tumors (1406) 1406
aged (1276) 1276
adult (1101) 1101
neuroendocrine tumors - drug therapy (1075) 1075
metastasis (1065) 1065
chemotherapy (984) 984
animals (840) 840
neuroendocrine tumors - pathology (784) 784
treatment outcome (775) 775
endocrinology & metabolism (746) 746
antineoplastic agents - therapeutic use (705) 705
prognosis (655) 655
medicine & public health (648) 648
surgery (638) 638
pancreatic neoplasms - drug therapy (613) 613
patients (582) 582
cancer therapies (558) 558
expression (533) 533
care and treatment (517) 517
management (500) 500
diagnosis (498) 498
carcinoma (495) 495
antineoplastic combined chemotherapy protocols - therapeutic use (493) 493
survival (488) 488
pancreatic neoplasms - pathology (474) 474
research (468) 468
somatostatin - analogs & derivatives (454) 454
therapy (451) 451
aged, 80 and over (449) 449
octreotide (445) 445
cell line, tumor (437) 437
everolimus (432) 432
neuroendocrine tumor (424) 424
somatostatin (413) 413
neuroendocrine (410) 410
carcinoma, neuroendocrine - drug therapy (409) 409
prostate cancer (404) 404
retrospective studies (399) 399
liver neoplasms - secondary (396) 396
mice (396) 396
metastases (390) 390
pancreas (385) 385
immunohistochemistry (379) 379
health aspects (374) 374
gastroenterology & hepatology (371) 371
octreotide - therapeutic use (367) 367
analysis (365) 365
carcinoma, neuroendocrine - pathology (360) 360
neuroendocrine tumors - therapy (358) 358
clinical trials (349) 349
neuroendocrine tumors - diagnosis (349) 349
neuroendocrine tumors - metabolism (345) 345
apoptosis (342) 342
medical prognosis (336) 336
neoplasm staging (329) 329
neuroendocrine differentiation (326) 326
pharmacology & pharmacy (316) 316
radiology, nuclear medicine & medical imaging (310) 310
studies (304) 304
prognostic-factors (303) 303
endocrine tumors (302) 302
pathology (300) 300
somatostatin - therapeutic use (300) 300
peptides (294) 294
medical research (292) 292
phase-ii (292) 292
mutation (287) 287
liver (273) 273
lung cancer (270) 270
review (268) 268
abridged index medicus (265) 265
disease progression (260) 260
neoplasms (258) 258
gene expression (255) 255
carcinoid (252) 252
disease-free survival (252) 252
drug therapy (245) 245
carcinoid-tumors (244) 244
prostatic neoplasms - pathology (244) 244
cell biology (243) 243
combined modality therapy (242) 242
neuroendocrine carcinoma (242) 242
neuroendocrine tumors - genetics (240) 240
medicine (236) 236
survival analysis (236) 236
growth (235) 235
antineoplastic agents - pharmacology (231) 231
endocrinology (228) 228
adenocarcinoma (226) 226
nuclear medicine (223) 223
tomography, x-ray computed (223) 223
antineoplastic agents, hormonal - therapeutic use (222) 222
lung neoplasms - drug therapy (221) 221
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6346) 6346
Japanese (59) 59
German (57) 57
French (47) 47
Italian (19) 19
Spanish (12) 12
Chinese (11) 11
Hungarian (10) 10
Polish (7) 7
Russian (6) 6
Danish (5) 5
Portuguese (5) 5
Finnish (3) 3
Korean (3) 3
Norwegian (3) 3
Arabic (2) 2
Croatian (1) 1
Czech (1) 1
Turkish (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 3, pp. 224 - 233
Journal Article
Journal Article
Science (American Association for the Advancement of Science), ISSN 1095-9203, 2017, Volume 355, Issue 6320, pp. 78 - 83
.... Additional loss of causes resistance to antiandrogen therapy. Gene expression profiling indicates that mouse tumors resemble human prostate cancer neuroendocrine variants... 
PATHWAY | MULTIDISCIPLINARY SCIENCES | MOUSE MODEL | SMALL-CELL CARCINOMA | PTEN | GENERATION | TUMORIGENESIS | EXPRESSION | DEFICIENCY | DELETION | EZH2 | Enhancer of Zeste Homolog 2 Protein - antagonists & inhibitors | Epigenesis, Genetic | Humans | SOXB1 Transcription Factors - antagonists & inhibitors | Male | Retinoblastoma-Like Protein p107 - genetics | Tumor Suppressor Protein p53 - genetics | Neoplasms, Experimental - pathology | Neoplasm Metastasis | Prostatic Neoplasms - genetics | SOXB1 Transcription Factors - genetics | Neoplasms, Experimental - genetics | Adenocarcinoma - genetics | Prostatic Neoplasms - drug therapy | Neuroendocrine Tumors - pathology | PTEN Phosphohydrolase - genetics | Prostatic Neoplasms - pathology | Enhancer of Zeste Homolog 2 Protein - genetics | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Neuroendocrine Tumors - genetics | Cell Lineage | Drug Resistance, Neoplasm - genetics | Animals | Androgen Antagonists - therapeutic use | Cell Line, Tumor | Neuroendocrine Tumors - drug therapy | Cell Plasticity | Mice | Mutation | Neoplasms, Experimental - drug therapy | Prevention | Antimitotic agents | Epigenetic inheritance | Development and progression | Genetic aspects | Dosage and administration | Metastasis | Gene expression | Antineoplastic agents | Drug resistance | Health aspects | Prostate cancer | Drugs | Therapy | Deprivation | Histology | Hormones | Suppressors | Switching | Signal transduction | Sensitivity | Androgens | Inhibitors | Rodents | Plasticity | Epigenetics | Tumor suppressor genes | Plastic properties | Prostate | Cancer | Tumors | Mutations
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10022, pp. 968 - 977
Journal Article
Endocrine-Related Cancer, ISSN 1351-0088, 03/2010, Volume 17, Issue 1, pp. R53 - R73
Somatostatin receptor imaging (SRI) with [ 111 In-DTPA 0 ]octreotide has proven its role in the diagnosis and staging of gastroenteropancreatic neuroendocrine tumors (GEPNETs... 
CELL LUNG-CANCER | PHASE-II TRIAL | ONCOLOGY | ANALOG SCINTIGRAPHY | CLINICAL IMPACT | RADIONUCLIDE THERAPY | CARCINOID-TUMORS | ENDOCRINOLOGY & METABOLISM | TYR OCTREOTATE | LOW-GRADE | QUALITY-OF-LIFE | OCTREOTIDE SCINTIGRAPHY | Humans | Digestive System Neoplasms - radiotherapy | Antineoplastic Agents - therapeutic use | Yttrium Radioisotopes - pharmacokinetics | Octreotide - pharmacokinetics | Digestive System Neoplasms - drug therapy | Gallium Radioisotopes - therapeutic use | Digestive System Neoplasms - diagnostic imaging | Neuroendocrine Tumors - diagnostic imaging | Receptors, Somatostatin - analysis | Organometallic Compounds - therapeutic use | Yttrium Radioisotopes - therapeutic use | Somatostatin - analogs & derivatives | Radiopharmaceuticals - pharmacokinetics | Octreotide - analogs & derivatives | Organometallic Compounds - pharmacokinetics | Treatment Outcome | Clinical Trials as Topic | Combined Modality Therapy | Indium Radioisotopes - pharmacokinetics | Positron-Emission Tomography - methods | Octreotide - therapeutic use | Somatostatin - pharmacokinetics | Peptides, Cyclic - pharmacokinetics | Neuroendocrine Tumors - radiotherapy | Animals | Organotechnetium Compounds - pharmacokinetics | Positron-Emission Tomography - standards | Receptors, Somatostatin - drug effects | Gallium Radioisotopes - pharmacokinetics | Neuroendocrine Tumors - drug therapy | Peptides, Cyclic - therapeutic use | Quality of Life | Indium Radioisotopes - therapeutic use | Somatostatin - therapeutic use | Radiopharmaceuticals - therapeutic use
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 16, pp. 1555 - 1557
...) are expressed in 70 to 90% of neuroendocrine tumors. The result on somatostatin-receptor scintigraphy is the most important factor that predicts the effectiveness of somatostatin analogue therapy... 
MEDICINE, GENERAL & INTERNAL | PET | SCINTIGRAPHY | Pancreatic Neoplasms - drug therapy | Somatostatin - analogs & derivatives | Gastrointestinal Neoplasms - drug therapy | Humans | Neuroendocrine Tumors - drug therapy | Peptides, Cyclic - therapeutic use | Female | Male | Antineoplastic Agents - therapeutic use | Tomography | Octreotide | Scintigraphy | Somatostatin | Somatostatin receptors | Neuroendocrine tumors | Metastases
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9808, pp. 2005 - 2012
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 364, Issue 6, pp. 514 - 523
Journal Article
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 2/2014, Volume 41, Issue 2, pp. 223 - 230
Journal Article